Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study

被引:56
|
作者
Papadimitriou, Dimitra [1 ,2 ]
Antonelou, Roubina [3 ]
Miligkos, Michael [4 ]
Maniati, Matina [2 ]
Papagiannakis, Nikolaos [2 ,3 ]
Bostantjopoulou, Sevasti [5 ]
Leonardos, Athannassios [3 ]
Koros, Christos [3 ]
Simitsi, Athina [3 ]
Papageorgiou, Sokratis G. [3 ]
Kapaki, Elisabeth [6 ]
Alcalay, Roy N. [7 ]
Papadimitriou, Alexandros [1 ]
Athanassiadou, Aglaia [8 ]
Stamelou, Maria [3 ,9 ,10 ]
Stefanis, Leonidas [2 ,3 ]
机构
[1] Henry Dunant Hosp Ctr, 107 Mesog Ave, Athens 11526, Greece
[2] Acad Athens BRFAA, Biomed Res Fdn, Athens, Greece
[3] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Neurol 2, Athens, Greece
[4] Univ Thessaly, Lab Biomath, Sch Med, Larisa, Greece
[5] Aristotle Univ Thessaloniki, Univ Dept Neurol 3, Thessaloniki, Greece
[6] Univ Athens, Eginit Univ Hosp, Sch Med, Dept Neurol 1, Athens, Greece
[7] Columbia Univ, Med Ctr, New York, NY USA
[8] Univ Patras, Fac Med, Dept Gen Biol, Rion, Greece
[9] Univ Marburg, Neurol Clin, Marburg, Germany
[10] Hygeia Hosp, Movement Disorders Dept, Athens, Greece
关键词
Parkinson's disease; alpha-synuclein; penetrance; asymptomatic; A53T; PARKINSONS-DISEASE; GENETIC-ANALYSIS; PENETRANCE; GREECE; DEPRESSION; PHENOTYPE; DEMENTIA; FAMILIES; CARRY;
D O I
10.1002/mds.26615
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundG209A SNCA mutation carriers represent an important group of genetic PD. We describe motor and nonmotor features of G209A SNCA mutation carriers. MethodsLongitudinal clinical assessments over 2 years were collected in 22 symptomatic and 8 asymptomatic G209A SNCA mutation carriers. Motor and nonmotor rating scales were administered. Correlations were performed between clinical variables and disease duration or age. Penetrance was calculated using Kaplan-Meier survival curves. ResultsAsymptomatic carriers did not manifest clear premotor symptoms, but symptomatic carriers often reported that olfactory dysfunction and rapid eye movement sleep behavior disorder preceded motor symptoms. Prominent motor decline and deterioration of autonomic and cognitive function occurred at follow-up; such nonmotor features correlated with disease duration, but not age. Disease penetrance was estimated at around 90%. ConclusionsThis study may help to inform clinical trials and provide the basis for studies of disease modifiers in genetic synucleinopathy cohorts. (c) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码:1226 / 1230
页数:5
相关论文
共 50 条
  • [1] Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study
    Simitsi, Athina Maria
    Sfikas, Evangelos
    Koros, Christos
    Papagiannakis, Nikolaos
    Beratis, Ion
    Papadimitriou, Dimitra
    Antonellou, Roubina
    Fragiadaki, Styliani
    Kontaxopoulou, Dionysia
    Picillo, Marina
    Pachi, Ioanna
    Alefanti, Ioanna
    Stamelou, Maria
    Barone, Paolo
    Stefanis, Leonidas
    JOURNAL OF NEUROLOGY, 2025, 272 (03)
  • [2] Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene
    Bougea, Anastasia
    Koros, Christos
    Stamelou, Maria
    Simitsi, Athina
    Papagiannakis, Nikolaos
    Antonelou, Roubina
    Papadimitriou, Dimitra
    Breza, Marianthi
    Tasios, Konstantinos
    Fragkiadaki, Stella
    Trapali, Xenia Geronicola
    Bourbouli, Mara
    Koutsis, Georgios
    Papageorgiou, Sokratis G.
    Kapaki, Elisabeth
    Paraskevas, George P.
    Stefanis, Leonidas
    PARKINSONISM & RELATED DISORDERS, 2017, 35 : 82 - 87
  • [3] Non-motor symptoms in a cohort of asymptomatic for PD, carriers of the p.A53T alpha-synuclein (SNCA) mutation
    Simitsi, A. M.
    Koros, C.
    Stamelou, M.
    Papadimitriou, D.
    Antonellou, R.
    Papagiannakis, N.
    Bonakis, A.
    Stefanis, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 639 - 639
  • [4] Sleep disorders and other non-motor symptoms in a cohort of p.A53T alpha-synuclein (SNCA) mutation carriers.
    Simitsi, A.
    Koros, C.
    Stamelou, M.
    Papagiannakis, N.
    Papadimitriou, D.
    Bonakis, A.
    Stefanis, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 176 - 176
  • [5] The different faces of the p.A53T alpha-synuclein mutation: A screening of Greek patients with parkinsonism and/or dementia
    Breza, M.
    Koutsis, G.
    Kartanou, C.
    Karadima, G.
    Potagas, C.
    Papageorgiou, S. G.
    Paraskevas, G.
    Kapaki, E.
    Stefanis, L.
    Panas, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 418 - 418
  • [6] Non-motor features of p.A53T a-synuclein mutation carriers compared to sporadic Parkinson's disease in a PPMI cohort
    Stamelou, M.
    Koros, C.
    Simitsi, A.
    Beratis, I.
    Trapali, X. Geronicola
    Papadimitriou, D.
    Papagiannakis, N.
    Prentakis, A.
    Kontaxopoulou, D.
    Fragkiadaki, S.
    Antonelou, R.
    Papageorgiou, S.
    Stefanis, L.
    MOVEMENT DISORDERS, 2017, 32
  • [7] Non-motor and neuropsychological features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson's disease in a PPMI cohort
    Koros, C.
    Stamelou, M.
    Simitsi, A. M.
    Beratis, I.
    Papadimitriou, D.
    Papagiannakis, N.
    Kontaxopoulou, D.
    Fragkiadaki, S.
    Trapali, X. Geronicola
    Prentakis, A.
    Antonelou, R.
    Bonakis, A.
    Papageorgiou, S. G.
    Stefanis, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 558 - 558
  • [8] Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson ' s disease
    Nishioka, Kenya
    Hashizume, Yoshio
    Takanashi, Masashi
    Daida, Kensuke
    Li, Yuanzhe
    Yoshino, Hiroyo
    Tambasco, Nicola
    Prontera, Paolo
    Hattori, Yuko
    Ueda, Akihiro
    Watanabe, Hirohisa
    Hattori, Nobutaka
    PARKINSONISM & RELATED DISORDERS, 2020, 81 : 183 - 187
  • [9] Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson?s Disease: Data from the PPMI Study
    Koros, Christos
    Simitsi, Athina-Maria
    Papadimitriou, Dimitra
    Bougea, Anastasia
    Prentakis, Andreas
    Papagiannakis, Nikolaos
    Pachi, Ioanna
    Bozi, Marria
    Antonelou, Roubina
    Angelopoulou, Efthalia
    Beratis, Ion
    Papageorgiou, Sokratis G.
    Trapali, Xenia Geronicola
    Stamelouaef, Maria
    Stefanis, Leonidas
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 481 - 487
  • [10] Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson's disease: Longitudinal data from the PPMI study
    Koros, C.
    Simitsi, A. M.
    Stamelou, M.
    Papadimitriou, D.
    Bougea, A.
    Pachi, I.
    Papagiannakis, N.
    Prentakis, A.
    Angelopoulou, E.
    Antonellou, R.
    Bozi, M.
    Trapali, X. Geronicola
    Stefanis, L.
    MOVEMENT DISORDERS, 2019, 34